Literature DB >> 31914918

Evaluation of resazurin-based assay for rapid detection of polymyxin-resistant gram-negative bacteria.

Huaiyu Jia1,2, Renchi Fang1, Jie Lin1, Xuebin Tian2, Yajie Zhao2, Lijiang Chen1, Jianming Cao3, Tieli Zhou4.   

Abstract

BACKGROUND: Colistin resistance is considered a serious problem due to a lack of alternative antibiotics. The Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test is a resazurin reduction-based technique that relies on the visual detection of bacterial growth in the presence of a defined concentration of colistin. The aim of this study was to evaluate the performance of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test in the detection of colistin susceptibility in common clinical Gram-negative bacteria.
RESULTS: A total of 253 clinical isolates from a teaching hospital, including Acinetobacter baumanii (n = 58, 8 colistin-resistant), Pseudomonas aeruginosa (n = 61, 11 colistin-resistant), Klebsiella pneumoniae (n = 70, 20 colistin-resistant) and Escherichia coli (n = 64, 14 colistin-resistant) were tested in this study. The sensitivity and specificity of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test compared to Broth microdilution method was 100 and 99%, respectively.
CONCLUSIONS: Our results suggest that Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test could be used as an accurate detection method for colistin resistance.

Entities:  

Keywords:  Colistin-resistant; Gram-negative bacteria; Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test; Rapid diagnosis

Mesh:

Substances:

Year:  2020        PMID: 31914918      PMCID: PMC6950887          DOI: 10.1186/s12866-019-1692-3

Source DB:  PubMed          Journal:  BMC Microbiol        ISSN: 1471-2180            Impact factor:   3.605


Background

Polymyxin E, also known as colistin is a multicomponent polypeptide antibiotic, which belongs to the group of polymyxin [1]. Polymyxin E was discovered in the 1940s; yet, later on, it was abandoned in clinical practice due to its increased nephrotoxicity. However, due to the increase of multidrug resistance (MDR) in Gram-negative bacteria, especially in the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), colistin has been applied in clinical practice for the last few years as the last resort treatment option [2, 3]. Currently, colistin resistance is considered a serious problem, due to a lack of alternative antibiotics [4, 5]. As for now, rapid identification of colistin resistance is considered essential for the effective control of MDR Gram-negative bacteria infection. Broth microdilution (BMD) is the only reference method that has been recommended by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) for the detection of minimum inhibitory concentrations (MICs) of colistin [6, 7]. Nevertheless, colistin antimicrobial susceptibility testing is very challenging to perform [8, 9]. For example, the operational steps of BMD are complex and time-consuming, making it unsuitable for clinical use [10]. Clinical microbiology laboratories are especially affected by the lack of an accurate, fast and easy-to-conduct method to test the colistin susceptibility [11-13]. Therefore, it is of great significance for clinical anti-infective treatment to develop and promote new, convenient, economical, rapid and accurate colistin sensitivity detection method. In 2016, Nordmann et al developed the Rapid Polymyxins NP test for Enterobacteriaceae spp [14]. The method can be used to detect bacteria that can grow, metabolize glucose, and produce acid in the presence of polymyxin such as polymyxin B or colistin through color changes of PH indicators. However, one of the significant limitations when using this approach is that it cannot be applied for non-fermentative bacteria such as A. baumannii and P. aeruginosa. More recently, Lescat et al have developed a rapid resazurin-mucoid susceptibility test method called Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test, which can quickly detect the sensitivity of colistin for both Enterobacteriaceae spp and non-fermentative bacteria within 4 h [15]. The method is mainly based on detection of the strain viability by observing the color change of resazurin (an active colorant) from blue to purple or pink in the presence of colistin (3.75 mg/L). In this study, we analyzed the performance of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test in the detection of colistin susceptibility in 253 nonduplicate clinical Gram-negative isolates aiming to provide a basis for the popularization and application of a new method for rapid screening of colistin-resistant common clinical Gram-negative bacteria.

Results

The colistin MICs of the 253 Gram-negative isolates ranged from ≤0.06 to ≥32 mg/L. BMD results were used as a standard, and 53 colistin-resistant strains and 198 colistin susceptible strains were correctly detected by the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test. Very major errors (VME) and major errors (ME) corresponded to false-susceptible and false-resistant results, respectively [16]. There were only two ME in A. baumannii; details are shown in Tables 1 and 2. The specificity of A. baumannii was 96%; while the sensitivity and specificity of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test to P. aeruginosa, K. pneumoniae and E. coli were 100% (Table 3).
Table 1

Colistin MICs obtained by broth microdilution and results of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test

IsolateSpeciesResistant PhenotypeMIC (mg/L)Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP Test
ResultDiscrepancies with BMD MIC colistin result
BM1539A. baumanniiR8PositiveNo
BM1579A. baumanniiR4PositiveNo
BM1595A. baumanniiR4PositiveNo
BM2349A. baumanniiR4PositiveNo
BM2370A. baumanniiR16PositiveNo
BM2412A. baumanniiR4PositiveNo
BM2431A. baumanniiR8PositiveNo
BM2622A. baumanniiR8PositiveNo
TL1671P. aeruginosaR4PositiveNo
TL1722P. aeruginosaR4PositiveNo
TL1736P. aeruginosaR≥32PositiveNo
TL1744P. aeruginosaR4PositiveNo
TL2204P. aeruginosaR4PositiveNo
TL2294P. aeruginosaR4PositiveNo
TL2314P. aeruginosaR≥32PositiveNo
TL2917P. aeruginosaR4PositiveNo
TL2967P. aeruginosaR4PositiveNo
TL3008P. aeruginosaR16PositiveNo
TL3086P. aeruginosaR≥32PositiveNo
FK20K. pneumoniaeR≥32PositiveNo
FK26K. pneumoniaeR≥32PositiveNo
FK150K. pneumoniaeR≥32PositiveNo
FK169K. pneumoniaeR≥32PositiveNo
FK171K. pneumoniaeR≥32PositiveNo
FK591K. pneumoniaeR≥32PositiveNo
FK610K. pneumoniaeR≥32PositiveNo
FK1342K. pneumoniaeR≥32PositiveNo
FK1913K. pneumoniaeR≥32PositiveNo
FK1986K. pneumoniaeR8PositiveNo
FK2066K. pneumoniaeR≥32PositiveNo
FK2166K. pneumoniaeR≥32PositiveNo
FK2778K. pneumoniaeR≥32PositiveNo
FK2911K. pneumoniaeR≥32PositiveNo
FK3789K. pneumoniaeR≥32PositiveNo
FK3810K. pneumoniaeR≥32PositiveNo
FK3994K. pneumoniaeR≥32PositiveNo
FK6556K. pneumoniaeR32PositiveNo
FK6663K. pneumoniaeR32PositiveNo
FK6696K. pneumoniaeR16PositiveNo
DC90E. coliR8PositiveNo
DC2562E. coliR8PositiveNo
DC3411E. coliR4PositiveNo
DC3539E. coliR16PositiveNo
DC3599E. coliR8PositiveNo
DC3658E. coliR8PositiveNo
DC3737E. coliR8PositiveNo
DC3802E. coliR4PositiveNo
DC3806E. coliR8PositiveNo
DC3846E. coliR16PositiveNo
DC4887E. coliR8PositiveNo
DC5262E. coliR8PositiveNo
DC5286E. coliR8PositiveNo
DC7333E. coliR4PositiveNo
BM1505A. baumanniiS0.125NegativeNo
BM1506A. baumanniiS0.5NegativeNo
BM1507A. baumanniiS0.06NegativeNo
BM1508A. baumanniiS0.125NegativeNo
BM1509A. baumanniiS0.125NegativeNo
BM1510A. baumanniiS0.125NegativeNo
BM1511A. baumanniiS0.125NegativeNo
BM1512A. baumanniiS0.25NegativeNo
BM1513A. baumanniiS0.125NegativeNo
BM1514A. baumanniiS0.125NegativeNo
BM4151A. baumanniiS0.25NegativeNo
BM4152A. baumanniiS0.06NegativeNo
BM4153A. baumanniiS0.03NegativeNo
BM4154A. baumanniiS0.125NegativeNo
BM4155A. baumanniiS0.125NegativeNo
BM4156A. baumanniiS0.125NegativeNo
BM4158A. baumanniiS0.125NegativeNo
BM4159A. baumanniiS0.125NegativeNo
BM4160A. baumanniiS0.5NegativeNo
BM4161A. baumanniiS0.125NegativeNo
BM4162A. baumanniiS0.06NegativeNo
BM4163A. baumanniiS0.06NegativeNo
BM4164A. baumanniiS0.06NegativeNo
BM4165A. baumanniiS0.06NegativeNo
BM4166A. baumanniiS0.125NegativeNo
BM4167A. baumanniiS0.125NegativeNo
BM4168A. baumanniiS0.25NegativeNo
BM4169A. baumanniiS0.5NegativeNo
BM4170A. baumanniiS0.125NegativeNo
BM4171A. baumanniiS0.06NegativeNo
BM4172A. baumanniiS≤0.06NegativeNo
BM4173A. baumanniiS0.06NegativeNo
BM4174A. baumanniiS0.06NegativeNo
BM4175A. baumanniiS2NegativeNo
BM4176A. baumanniiS0.06NegativeNo
BM4177A. baumanniiS0.06NegativeNo
BM4178A. baumanniiS0.06NegativeNo
BM4179A. baumanniiS0.25NegativeNo
BM4180A. baumanniiS0.06NegativeNo
BM4181A. baumanniiS0.125NegativeNo
BM4182A. baumanniiS0.25NegativeNo
BM4183A. baumanniiS1NegativeNo
BM4184A. baumanniiS1PositiveYes, ME
BM4185A. baumanniiS1NegativeNo
BM4186A. baumanniiS1NegativeNo
BM4187A. baumanniiS0.125NegativeNo
BM4188A. baumanniiS0.5PositiveYes, ME
BM4189A. baumanniiS0.5NegativeNo
BM4190A. baumanniiS0.125NegativeNo
BM4191A. baumanniiS0.5NegativeNo
TL2916P. aeruginosaS0.125NegativeNo
TL2915P. aeruginosaS≤0.06NegativeNo
TL2914P. aeruginosaS0.125NegativeNo
TL2913P. aeruginosaS0.125NegativeNo
TL2911P. aeruginosaS0.125NegativeNo
TL2910P. aeruginosaS0.25NegativeNo
TL2908P. aeruginosaS0.125NegativeNo
TL2907P. aeruginosaS0.5NegativeNo
TL2906P. aeruginosaS0.125NegativeNo
TL2905P. aeruginosaS0.125NegativeNo
TL2904P. aeruginosaS0.125NegativeNo
TL2901P. aeruginosaS0.125NegativeNo
TL2899P. aeruginosaS0.125NegativeNo
TL2898P. aeruginosaS0.125NegativeNo
TL2897P. aeruginosaS0.125NegativeNo
TL2895P. aeruginosaS0.125NegativeNo
TL2893P. aeruginosaS≤0.06NegativeNo
TL2892P. aeruginosaS0.125NegativeNo
TL2891P. aeruginosaS0.06NegativeNo
TL2890P. aeruginosaS0.25NegativeNo
TL2889P. aeruginosaS0.5NegativeNo
TL2886P. aeruginosaS0.5NegativeNo
TL2885P. aeruginosaS0.25NegativeNo
TL2884P. aeruginosaS0.25NegativeNo
TL2883P. aeruginosaS0.5NegativeNo
TL2882P. aeruginosaS0.25NegativeNo
TL2881P. aeruginosaS0.25NegativeNo
TL2879P. aeruginosaS0.25NegativeNo
TL2878P. aeruginosaS0.25NegativeNo
TL2877P. aeruginosaS0.25NegativeNo
TL2875P. aeruginosaS0.25NegativeNo
TL2874P. aeruginosaS0.25NegativeNo
TL2873P. aeruginosaS1NegativeNo
TL2872P. aeruginosaS0.125NegativeNo
TL2871P. aeruginosaS0.25NegativeNo
TL2870P. aeruginosaS2NegativeNo
TL2869P. aeruginosaS0.125NegativeNo
TL2868P. aeruginosaS0.125NegativeNo
TL2867P. aeruginosaS0.125NegativeNo
TL2866P. aeruginosaS0.125NegativeNo
TL2865P. aeruginosaS0.125NegativeNo
TL2864P. aeruginosaS0.25NegativeNo
TL2863P. aeruginosaS≤0.06NegativeNo
TL2862P. aeruginosaS0.125NegativeNo
TL2861P. aeruginosaS0.25NegativeNo
TL2858P. aeruginosaS0.25NegativeNo
TL2857P. aeruginosaS0.25NegativeNo
TL2856P. aeruginosaS0.125NegativeNo
TL2855P. aeruginosaS0.25NegativeNo
TL2854P. aeruginosaS0.125NegativeNo
FK3640K. pneumoniaeS≤0.06NegativeNo
FK3642K. pneumoniaeS≤0.06NegativeNo
FK3646K. pneumoniaeS≤0.06NegativeNo
FK3660K. pneumoniaeS≤0.06NegativeNo
FK3671K. pneumoniaeS0.125NegativeNo
FK3686K. pneumoniaeS0.5NegativeNo
FK3695K. pneumoniaeS≤0.06NegativeNo
FK3696K. pneumoniaeS≤0.06NegativeNo
FK3703K. pneumoniaeS≤0.06NegativeNo
FK3712K. pneumoniaeS≤0.06NegativeNo
FK3719K. pneumoniaeS≤0.06NegativeNo
FK3721K. pneumoniaeS≤0.06NegativeNo
FK3724K. pneumoniaeS1NegativeNo
FK3727K. pneumoniaeS0.5NegativeNo
FK3730K. pneumoniaeS≤0.06NegativeNo
FK3732K. pneumoniaeS0.25NegativeNo
FK3738K. pneumoniaeS≤0.06NegativeNo
FK3739K. pneumoniaeS0.125NegativeNo
FK3740K. pneumoniaeS≤0.06NegativeNo
FK3741K. pneumoniaeS≤0.06NegativeNo
FK3745K. pneumoniaeS0.5NegativeNo
FK3746K. pneumoniaeS1NegativeNo
FK3749K. pneumoniaeS≤0.06NegativeNo
FK3758K. pneumoniaeS≤0.06NegativeNo
FK3764K. pneumoniaeS≤0.06NegativeNo
FK3767K. pneumoniaeS≤0.06NegativeNo
FK3771K. pneumoniaeS0.5NegativeNo
FK3784K. pneumoniaeS≤0.06NegativeNo
FK3800K. pneumoniaeS0.5NegativeNo
FK3803K. pneumoniaeS0.25NegativeNo
FK3813K. pneumoniaeS≤0.06NegativeNo
FK3817K. pneumoniaeS≤0.06NegativeNo
FK3824K. pneumoniaeS0.06NegativeNo
FK3830K. pneumoniaeS≤0.06NegativeNo
FK3831K. pneumoniaeS≤0.06NegativeNo
FK3838K. pneumoniaeS0.5NegativeNo
FK3844K. pneumoniaeS0.125NegativeNo
FK3853K. pneumoniaeS0.125NegativeNo
FK3878K. pneumoniaeS0.25NegativeNo
FK3882K. pneumoniaeS≤0.06NegativeNo
FK3891K. pneumoniaeS≤0.06NegativeNo
FK3927K. pneumoniaeS0.125NegativeNo
FK3938K. pneumoniaeS0.5NegativeNo
FK3943K. pneumoniaeS0.06NegativeNo
FK3946K. pneumoniaeS0.5NegativeNo
FK3989K. pneumoniaeS≤0.06NegativeNo
FK3990K. pneumoniaeS1NegativeNo
FK3996K. pneumoniaeS0.125NegativeNo
FK3999K. pneumoniaeS≤0.06NegativeNo
FK4002K. pneumoniaeS≤0.06NegativeNo
DC8640E. coliS0.25NegativeNo
DC8641E. coliS≤0.06NegativeNo
DC8642E. coliS0.125NegativeNo
DC8643E. coliS0.125NegativeNo
DC8644E. coliS0.5NegativeNo
DC8645E. coliS≤0.06NegativeNo
DC8646E. coliS≤0.06NegativeNo
DC8647E. coliS≤0.06NegativeNo
DC8648E. coliS≤0.06NegativeNo
DC8649E. coliS0.125NegativeNo
DC8650E. coliS0.06NegativeNo
DC8651E. coliS0.06NegativeNo
DC8652E. coliS0.125NegativeNo
DC8653E. coliS0.06NegativeNo
DC8654E. coliS0.06NegativeNo
DC8655E. coliS0.06NegativeNo
DC8656E. coliS0.125NegativeNo
DC8657E. coliS≤0.06NegativeNo
DC8658E. coliS0.06NegativeNo
DC8659E. coliS≤0.06NegativeNo
DC8660E. coliS≤0.06NegativeNo
DC8661E. coliS≤0.06NegativeNo
DC8663E. coliS0.125NegativeNo
DC8664E. coliS2NegativeNo
DC8665E. coliS≤0.06NegativeNo
DC8666E. coliS0.06NegativeNo
DC8667E. coliS≤0.06NegativeNo
DC8668E. coliS≤0.06NegativeNo
DC8669E. coliS≤0.06NegativeNo
DC8670E. coliS≤0.06NegativeNo
DC8671E. coliS≤0.06NegativeNo
DC8672E. coliS≤0.06NegativeNo
DC8673E. coliS≤0.06NegativeNo
DC8674E. coliS0.06NegativeNo
DC8675E. coliS≤0.06NegativeNo
DC8676E. coliS≤0.06NegativeNo
DC8677E. coliS≤0.06NegativeNo
DC8678E. coliS≤0.06NegativeNo
DC8679E. coliS≤0.06NegativeNo
DC8680E. coliS0.25NegativeNo
DC8681E. coliS2NegativeNo
DC8682E. coliS0.125NegativeNo
DC8683E. coliS≤0.06NegativeNo
DC8684E. coliS≤0.06NegativeNo
DC8685E. coliS≤0.06NegativeNo
DC8686E. coliS0.06NegativeNo
DC8687E. coliS0.06NegativeNo
DC8688E. coliS0.06NegativeNo
DC8690E. coliS0.06NegativeNo
DC8691E. coliS0.125NegativeNo

ME major error, S susceptible, R resistant

Table 2

Colistin MICs for 253 Gram-negative isolates

OrganismNumber of isolatesColistin MIC (mg/L)
≤0.060.1250.250.5124816≥32
Total25386562719841413521
A. baumannii58151956414310
P. aeruginosa61423174117013
K. pneumoniae70306383001118
E. coli6437821023920
Table 3

Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test results among Gram-negative isolates

OrganismSusceptibility to polymyxinsResistance mechanismIsolatesRapid ResaPolymyxin Acinetobacter/Pseudomonas NP testSensitivitySpecificity
A. baumanniiResistantMediated by chromosomea8 (3.16%)8 positive result100%96%
Susceptible50 (19.76%)48 negative results and 2 positive result
P. aeruginosaResistantMediated by chromosome11 (4.35%)11 positive result100%100%
Susceptible50 (19.76%)50 negative results
K. pneumoniaeResistantMediated by chromosomea20 (7.91%)20 positive result100%100%
Susceptible50 (19.76%)50 negative results
E. coliResistantMediated by plasmid14 (5.54%)2 positive result100%100%
Susceptible50 (19.76%)50 negative results

aUnpublished

Colistin MICs obtained by broth microdilution and results of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test ME major error, S susceptible, R resistant Colistin MICs for 253 Gram-negative isolates Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test results among Gram-negative isolates aUnpublished

Discussion

In this study, we described the diagnostic performance of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test, a phenotypic method for differentiation between colistin-resistant strains and colistin-susceptible strains. Compared with the reference BMD, the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test showed accuracy in detecting the resistance to colistin. Besides, the method was fast, easy to perform, and the obtained data were easy to interpret. Rapid Polymyxin NP test makes up for the limitations of applicability in non-fermenters [14]. In our study, we examined it efficiency in detecting non-fermentative bacteria, but also fermentative bacteria, such as E. coli strains and K. pneumoniae strains. The results showed that the sensitivity and specificity of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test to Enterobacteriaceae were 100%, which was consistent with a previous study [15]. In the present study, there were only two ME in colistin-susceptible A. baumannii strains. The categorical agreement for all tested isolates was 99.2% for the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test. In addition, the sensitivity and specificity were respectively 100 and 99%, which further suggested that this method is suitable for detecting fermentative bacteria. So far, a number of studies have examined the mechanism of colistin resistance [17, 18]. This study revealed that chromosome mutations of two-component regulatory systems (TCSs) and mcr-1, which were located in plasmid, were the main causes of colistin resistance in 53 strains. In addition, we were able to detect drug resistance without a difference. Therefore, compared with the Rapid Polymyxin NP test, the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test is suitable to be used in more scenes. MicroScan Colistin Well is a newly developed kit for detection of colistin resistance in Gram-negative bacteria [19]. The fundamental principle of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test is similar to MicroScan Colistin Well. Both methods can be used to detect living bacteria in the medium with 4 mg/L or 3.75 mg/L of colistin (close to the breakpoint of colistin resistance). Similarly, the MICs cannot be determined utilizing the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test and the MicroScan Colistin Well. Only colistin resistance results or sensitive test results can be obtained by them. However, there are two major differences between the two methods. First, Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test is significantly faster compared to MicroScan Colistin Well. For example, the detection of P. aeruginosa by Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test takes maximum 5 h to analyze the results, while MicroScan Colistin Well requires 16 to 18 h. Secondly, in the presence of resazurin reagent PrestoBlue®, the growth of living bacteria of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test can be more clearly observed compared to MicroScan Colistin Well. The principle of Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test is based on the visual detection of the reduction of the resazurin reagent, a viability colorant that is observed by color change (blue to purple or pink). Interestingly, in the current study, no significant color changes were observed in colistin-resistant P. aeruginosa after the addition of the resazurin reagent for 1 h. After prolonging the observation time for another 1 h, the color changed from blue to purple. In other words, the results were not obtained until 2 h later in the study, while very obvious color changes were observed 15 min after the addition of the resazurin reagent in the colistin-resistant strains of A. baumanii, K. pneumoniae and E. coli, including 2 ME. This may be because the growth rate of P. aeruginosa is slower than that of Enterobacteriaceae, thus taking longer to decompose resazurin into fluorescent substance resorufin. It suggested that the observation time of the results of this experiment needed to be optimized according to the strain. However, the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test still has some limitations. Firstly, the accurate MIC values could not be obtained. Since the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test was not suitable for the study of high-level drug resistant strains, the method could only show whether the colistin resistant was present or not. Secondly, several mcr-harboring isolates with an MIC of 2 mg/L (or even less) to colistin or polymyxin B have been reported [20, 21], while our method could only be used to screen colistin resistant strains with MIC ≥4 mg/L. Thirdly, the reading time of P. aeruginosa results was different from that reported by the inventors, requiring an additional 1 h of observation time.

Conclusion

The Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test has great stability and sensitivity in detection of colistin resistance in Gram-negative bacteria such as A. baumanii, P. aeruginosa, K. pneumoniae and E. coli strains. In addition, this method is fast and easy to perform. It can contribute in selecting more precise therapeutic choices, and optimizing antibiotic stewardship, and preventing the development of outbreaks with multidrug-resistant isolates. Nevertheless, the testing time of P. aeruginosa is longer than that reported by the inventor, so the observation time of this method needs to be further optimized.

Methods

Bacterial strains

A total of 253 nonduplicate clinical Gram-negative isolates including A. baumanii strains (n = 58), P. aeruginosa strains (n = 61), K. pneumoniae strains (n = 70) and E. coli strains (n = 64) were obtained from a teaching hospital in Wenzhou, China. Species identification was performed using the Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF MS, Bruker Daltonics, US). A total of 53 colistin-resistant strains were selected from our previous studies and were detected by BMD, including 8 A. baumanii strains, 11 P. aeruginosa strains, 20 K. pneumoniae strains and 14 E. coli strains. In addition, 50 colistin-susceptible isolates of each four bacterial species mentioned above were randomly selected as the control group. E. coli ATCC 25922 and P. aeruginosa ATCC 27853 were used as control strains [6].

Antimicrobial susceptibility test

BMD was performed in triplicate. According to the EUCAST/CLSI joined guidelines [6, 7], the clinical breakpoints for colistin provided for P. aeruginosa and A. baumanii were ≤ 2 mg/L (susceptible breakpoint) and ≥ 4 mg/L (resistant breakpoint) and Enterobacteriaceae are ≤2 mg/L (susceptible breakpoint) and > 2 mg/L (resistant breakpoint).

Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test

The experimental procedure was performed according to the previously described protocol [15]. Briefly, the colistin-containing Mueller Hinton broth (MHB, OXOID, UK) solution was prepared with an initial concentration of 4.16 mg/L. Then, a 180 μl colistin-free MHB solution and colistin-containing MHB solution were added to lines A and B of a 96-well polystyrene micro test plate, respectively. For each isolate, 20 μl of the bacterial suspension at a 3.5 McFarland optical density (~ 1 × 109 CFU/mL) was inoculated in parallel into two wells, with and without colistin. The bacterial suspension was mixed with the medium by pipetting up and down. The final concentration of colistin was 3.75 mg/L. In the same way, 20 μl of 0.85% NaCl was used as an aseptic control, 20 μl of the colistin-susceptible isolate (E. coli ATCC 25922 and P. aeruginosa ATCC 27853) suspension was used as negative control; and 20 μl of the colistin-resistant isolate (the clinical isolates of Morgan, inherent resistance to polymyxin) suspension was used as a positive control. After testing several isolates, we ensured that the color-transfer of colistin suspension and the mixing of bacterial suspension in the micro test plate were completed within 15 min. The inoculated tray was incubated at 35 ± 2 °C for 3 h. Then, 22 μl of the resazurin reagent PrestoBlue® (ThermoFisher Scientific, US, final concentration is 10% V/V) was added per well and each well was mixed by pipetting up and down. Finally, the tray was visually inspected every 15 min within 1 h. Susceptibility of colistin is determined by the color changes, where discoloration indicates that the strain is colistin-resistant, while the lack of discoloration indicates that the strain is colistin-susceptible [15]. All experiments were performed in triplicate. The test was considered to be positive (i.e., purple or pink) if the colistin-resistant isolate was viable in presence of colistin, or negative (i.e., blue) if the colistin-susceptible isolate was not viable in presence of colistin. The Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test interpretation is illustrated in Fig. 1.
Fig. 1

Representative results of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test. Non-inoculated well is shown as the control of the medium and the color changed (first column). Negative, the tested isolate only grows in the absence of colistin (second column). Positive, the tested isolate grows in the presence and absence of colistin (third column)

Representative results of the Rapid ResaPolymyxin Acinetobacter/Pseudomonas NP test. Non-inoculated well is shown as the control of the medium and the color changed (first column). Negative, the tested isolate only grows in the absence of colistin (second column). Positive, the tested isolate grows in the presence and absence of colistin (third column)
  19 in total

Review 1.  Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

Authors:  Jian Li; Roger L Nation; John D Turnidge; Robert W Milne; Kingsley Coulthard; Craig R Rayner; David L Paterson
Journal:  Lancet Infect Dis       Date:  2006-09       Impact factor: 25.071

2.  A Resazurin Reduction-Based Assay for Rapid Detection of Polymyxin Resistance in Acinetobacter baumannii and Pseudomonas aeruginosa.

Authors:  Mathilde Lescat; Laurent Poirel; Camille Tinguely; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

3.  Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study.

Authors:  Abiola Olumuyiwa Olaitan; Seydina M Diene; Marie Kempf; Meryem Berrazeg; Sofiane Bakour; Sushim Kumar Gupta; Boupha Thongmalayvong; Kongsap Akkhavong; Silaphet Somphavong; Phimpha Paboriboune; Kittipong Chaisiri; Chalit Komalamisra; Olawale Olufemi Adelowo; Obasola Ezekiel Fagade; Omowunmi Abosede Banjo; Adeyeye James Oke; Amos Adler; Marc Victor Assous; Serge Morand; Didier Raoult; Jean-Marc Rolain
Journal:  Int J Antimicrob Agents       Date:  2014-09-06       Impact factor: 5.283

Review 4.  Susceptibility testing of the polymyxins: where are we now?

Authors:  Romney M Humphries
Journal:  Pharmacotherapy       Date:  2014-10-20       Impact factor: 4.705

5.  The Search for a Practical Method for Colistin Susceptibility Testing: Have We Found It by Going Back to the Future?

Authors:  Michael J Satlin
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

6.  Molecular epidemiology of colistin-resistant Enterobacteriaceae in inpatient and avian isolates from China: high prevalence of mcr-negative Klebsiella pneumoniae.

Authors:  Xiaojuan Wang; Yuqing Liu; Xiaomei Qi; Ruobing Wang; Longyang Jin; Min Zhao; Yawei Zhang; Qi Wang; Hongbin Chen; Hui Wang
Journal:  Int J Antimicrob Agents       Date:  2017-06-28       Impact factor: 5.283

7.  Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?

Authors:  Shawn Vasoo
Journal:  J Clin Microbiol       Date:  2017-07-19       Impact factor: 5.948

Review 8.  Clinical Pharmacokinetics and Pharmacodynamics of Colistin.

Authors:  Nicolas Grégoire; Vincent Aranzana-Climent; Sophie Magréault; Sandrine Marchand; William Couet
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

9.  Comparison of methods for detection of plasmid-mediated and chromosomally encoded colistin resistance in Enterobacteriaceae.

Authors:  A Jayol; P Nordmann; P Lehours; L Poirel; V Dubois
Journal:  Clin Microbiol Infect       Date:  2017-06-09       Impact factor: 8.067

10.  Low level of polymyxin resistance among nonclonal mcr-1-positive Escherichia coli from human sources in Brazil.

Authors:  Marcelo Pillonetto; Alana Mazzetti; Guilherme N Becker; Christian A Siebra; Lavinia N V S Arend; Afonso L Barth
Journal:  Diagn Microbiol Infect Dis       Date:  2018-08-26       Impact factor: 2.803

View more
  2 in total

1.  Rapid ResaCeftazidime-Avibactam Enterobacterales NP Test: Rapid Detection of Ceftazidime-Avibactam Susceptibility in Enterobacterales.

Authors:  Luozhu Feng; Yining Zhao; Zhuocheng Yao; Xiaodong Zhang; Shufang Zheng; Lijiang Chen; Ying Zhang; Lingbo Wang; Tieli Zhou; Jianming Cao
Journal:  J Clin Microbiol       Date:  2022-08-10       Impact factor: 11.677

2.  RapidResa Polymyxin Acinetobacter NP® Test for Rapid Detection of Polymyxin Resistance in Acinetobacter baumannii.

Authors:  Maxime Bouvier; Mustafa Sadek; Stefano Pomponio; Fernando D'Emidio; Laurent Poirel; Patrice Nordmann
Journal:  Antibiotics (Basel)       Date:  2021-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.